Home › NDC Lookup › RxCUI directory › RxCUI 2104341

Cenegermin-bkbj 0.02 MG/ML Ophthalmic Solution [Oxervate] — RxCUI 2104341

Name: Cenegermin-bkbj 0.02 MG/ML Ophthalmic Solution [Oxervate] (RxCUI 2104341)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2104341 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2104341

Official nameCenegermin-bkbj 0.02 MG/ML Ophthalmic Solution [Oxervate]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asOxervate 0.002 % Ophthamic Solution; Oxervate 0.02 MG/ML Ophthalmic Solution; Oxervate 20 MCG/ML Ophthalmic Solution

FDA products mapped2

Package NDCs mapped2

Reported Medicaid activity (SDUD)1,558 prescriptions · 19 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cenegermin-bkbj Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Neurotrophic keratitis is a condition where the nerves supplying your cornea — the clear front part of your eye — become damaged. Without those nerve signals, your cornea can't fee...
What exactly is neurotrophic keratitis, and why do I need this medication?
The six-times-a-day schedule, every two hours, is the regimen that was tested in clinical trials and shown to work. It keeps a steady supply of the nerve growth factor on the surfa...
Why do I have to use these drops six times a day? That seems like a lot.

📖 Read our full Cenegermin-bkbj Ophthalmic guide →

🕸️ Concept Web — How Cenegermin-bkbj 0.02 MG/ML Ophthalmic Solution [... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Cenegermin-bkbj 0.02 MG/ML Ophthalmic Solution [Oxervate] RxCUI 2104341 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Cenegermin 2104332 IN
- Cenegermin-bkbj 2104331 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Oxervate 2104337 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Cenegermin Ophthalmic Solution 2104335 SCDF
- Cenegermin-bkbj Ophthalmic Solution 2645793 SCDFP
- Cenegermin Ophthalmic Product 2104334 SCDG
- Cenegermin-bkbj Ophthalmic Product 2660057 SCDGP
- Cenegermin Ophthalmic Solution [Oxervate] 2104339 SBDF
- Cenegermin-bkbj Ophthalmic Solution [Oxervate] 2657862 SBDFP
- Oxervate Ophthalmic Product 2104340 SBDG
- Ophthalmic Solution 7670 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Cenegermin-bkbj 0.02 MG/ML Ophthalmic Solution 2104336 SCD
- Cenegermin-bkbj 0.02 MG/ML 2104333 SCDC
- Cenegermin-bkbj 0.02 MG/ML [Oxervate] 2104338 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Cenegermin-bkbj 0.02 MG/ML Ophthalmic Solution SCD · 2104336
Cenegermin-bkbj 0.02 MG/ML SCDC · 2104333
Cenegermin Ophthalmic Solution SCDF · 2104335
Cenegermin-bkbj Ophthalmic Solution SCDFP · 2645793
Cenegermin Ophthalmic Product SCDG · 2104334
Cenegermin-bkbj Ophthalmic Product SCDGP · 2660057

Brand-Name Concepts

Cenegermin-bkbj 0.02 MG/ML [Oxervate] SBDC · 2104338
Cenegermin Ophthalmic Solution [Oxervate] SBDF · 2104339
Cenegermin-bkbj Ophthalmic Solution [Oxervate] SBDFP · 2657862
Oxervate Ophthalmic Product SBDG · 2104340
Oxervate BN · 2104337

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 2104341 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
71981-0001-01	1 KIT in 1 KIT (71981-001-01) * 7 VIAL, MULTI-DOSE in 1 CA...	OXERVATE	Domp farmaceutici S.p.A.	2018-11-26
71981-0020-07	7 VIAL, MULTI-DOSE in 1 CARTON (71981-020-07) / 1 mL in 1 V...	OXERVATE	Domp farmaceutici S.p.A.	2018-11-26

Observed labelers: Domp farmaceutici S.p.A. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.